Edition:
United States

Orexo AB (ORX.ST)

ORX.ST on Stockholm Stock Exchange

63.10SEK
12:00pm EDT
Change (% chg)

-1.50kr (-2.32%)
Prev Close
64.60kr
Open
64.60kr
Day's High
65.20kr
Day's Low
62.80kr
Volume
108,990
Avg. Vol
170,559
52-wk High
75.60kr
52-wk Low
28.10kr

Chart for

About

Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for respiratory and inflammatory diseases. The Company has four commercialized products, several projects... (more)

Overall

Beta: 1.71
Market Cap(Mil.): kr2,232.60
Shares Outstanding(Mil.): 34.56
Dividend: --
Yield (%): --

Financials

  ORX.ST Industry Sector
P/E (TTM): 28.36 30.43 32.65
EPS (TTM): 2.28 -- --
ROI: 16.48 13.04 12.72
ROE: 24.86 14.97 14.84

Orexo soars after winning opioid drug appeal against Teva

A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB's lawsuit accusing a unit of Israel's Teva Pharmaceutical Industries Ltd of infringing a patent for its opioid addiction drug Zubsolv.

Sep 10 2018

UPDATE 2-Orexo soars after winning opioid drug appeal against Teva

Sept 10 A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB's lawsuit accusing a unit of Israel's Teva Pharmaceutical Industries Ltd of infringing a patent for its opioid addiction drug Zubsolv.

Sep 10 2018

BRIEF-Orexo Q1 EBIT Loss At SEK 21.8 Million

* Q1 NET REVENUES SEK 139.7 MILLION VERSUS SEK 127.4 MILLION YEAR AGO

Apr 26 2018

Earnings vs. Estimates